Physician profile
Michael J Lee
NPI 1265429302
$109,427.82
in general payments reported to CMS, 2019-2025
16 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $231 · 2021: $353 · 2022: $105K · 2023: $396 · 2024: $2,669 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,500 · Consulting Fee: $1,000 · Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,500.00 |
| Consulting Fee | $1,000.00 |
| Food and Beverage | $800.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $104,375.13 | 2022 | |
| Motiva USA, LLC | $2,688.58 | 2024-2025 | |
| Globus Medical, INC. | $571.02 | 2019 | |
| Sientra, INC. | $313.23 | 2021 | |
| Allergan, INC. | $287.54 | 2019-2021 | |
| Tela Bio, INC. | $234.12 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $160.80 | 2023-2024 | |
| Revance Therapeutics, INC. | $150.00 | 2024 | Daxxify |
| Mentor Worldwide LLC | $148.02 | 2020 | |
| Endo Pharmaceuticals INC. | $147.46 | 2019 | |
| Abbott Laboratories | $136.54 | 2022 | |
| Galderma Laboratories, L.P. | $128.43 | 2022-2023 | Dysport |
| Glaxosmithkline, LLC. | $25.27 | 2025 | Arexvy, Shingrix |
| Astellas Pharma US INC | $22.55 | 2019 | |
| Merck Sharp & Dohme LLC | $21.38 | 2025 | Gardasil 9, Capvaxive |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $17.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.